Capstone Financial Advisors, Inc. Eli Lilly & CO Transaction History
Capstone Financial Advisors, Inc.
- $1.51 Billion
- Q2 2024
A detailed history of Capstone Financial Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 692 shares of LLY stock, worth $631,623. This represents 0.04% of its overall portfolio holdings.
Number of Shares
692
Previous 628
10.19%
Holding current value
$631,623
Previous $488,000
28.28%
% of portfolio
0.04%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
3,865Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$88.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$67.4 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$60.1 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$46.9 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$30.9 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $867B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...